{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:01:35Z","timestamp":1780786895287,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jacl.2026.03.020","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:14:29Z","timestamp":1774883669000},"page":"1277-1282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel MFN2 compound heterozygote genotype in a patient with multiple symmetric lipomatosis and metabolic dysfunction"],"prefix":"10.1016","volume":"20","author":[{"given":"Fabio Alexis","family":"Lefebvre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7555-1275","authenticated-orcid":false,"given":"Martine","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9534-1657","authenticated-orcid":false,"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jacl.2026.03.020_bib1","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jacl.2026.03.020_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biom8030047","article-title":"Genetics of Lipodystrophy: Can It Help in Understanding the Pathophysiology of Metabolic Syndrome?","volume":"8","author":"Mathur","year":"2018","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.jacl.2026.03.020_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158020","article-title":"Navigating Lipodystrophy: Insights from Laminopathies and Beyond","volume":"25","author":"Kr\u00fcger","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.020_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13023-024-03245-3","article-title":"Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey","volume":"19","author":"Patni","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.jacl.2026.03.020_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MOL.0000000000000613","article-title":"Recent developments in lipodystrophy","volume":"30","author":"Melvin","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2026.03.020_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116475","article-title":"Adipose tissue in health and disease","volume":"229","author":"Herrero","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacl.2026.03.020_bib7","article-title":"Molecular and Cellular Bases of Lipodystrophy Syndromes","volume":"12","author":"Zammouri","year":"2021","journal-title":"Front Endocrinol ((Lausanne))"},{"issue":"5685","key":"10.1016\/j.jacl.2026.03.020_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1099793","article-title":"Structural basis of mitochondrial tethering by mitofusin complexes","volume":"305","author":"Koshiba","year":"2004","journal-title":"Science"},{"issue":"7222","key":"10.1016\/j.jacl.2026.03.020_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature07534","article-title":"Mitofusin 2 tethers endoplasmic reticulum to mitochondria","volume":"456","author":"de Brito","year":"2008","journal-title":"Nature"},{"issue":"Pt 8","key":"10.1016\/j.jacl.2026.03.020_bib10","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/brain\/awl126","article-title":"MFN2 mutation distribution and genotype\/phenotype correlation in Charcot-Marie-Tooth type 2","volume":"129","author":"Verhoeven","year":"2006","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jacl.2026.03.020_bib11","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archneurol.2009.284","article-title":"Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations","volume":"66","author":"Calvo","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jacl.2026.03.020_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2350-11-48","article-title":"MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families","volume":"11","author":"Braathen","year":"2010","journal-title":"BMC Med Genet"},{"issue":"6","key":"10.1016\/j.jacl.2026.03.020_bib13","first-page":"299","article-title":"Madelung's disease","volume":"92","author":"Gossner","year":"2009","journal-title":"JBR-BTR"},{"issue":"6","key":"10.1016\/j.jacl.2026.03.020_bib14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SAP.0b013e3181d9aa55","article-title":"Madelung disease: on the morphologic criteria for diagnosis and treatment","volume":"64","author":"Hadjiev","year":"2010","journal-title":"Ann Plast Surg"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.020_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/21623945.2024.2416681","article-title":"Research progress on the pathogenesis of multiple symmetrical lipomatosis","volume":"13","author":"Hu","year":"2024","journal-title":"Adipocyte"},{"key":"10.1016\/j.jacl.2026.03.020_bib16","doi-asserted-by":"crossref","first-page":"iv","DOI":"10.1111\/ane.12013","article-title":"Genetic epidemiology of Charcot-Marie-Tooth disease","volume":"193","author":"Braathen","year":"2012","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.jacl.2026.03.020_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147684","article-title":"An integrative analysis of genotype-phenotype correlation in Charcot Marie Tooth type 2A disease with MFN2 variants: A case and systematic review","volume":"883","author":"Zhang","year":"2023","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.jacl.2026.03.020_bib18","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jacl.2018.07.009","article-title":"MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue","volume":"12","author":"Capel","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.03.020_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23813","article-title":"Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression","volume":"6","author":"Rocha","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.jacl.2026.03.020_bib20","doi-asserted-by":"crossref","first-page":"12505","DOI":"10.2147\/JIR.S530737","article-title":"The Lipid-Oxidative Stress Axis: Novel Therapeutic Targets for Podocytopathy","volume":"18","author":"Liu","year":"2025","journal-title":"J Inflamm Res"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.020_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40001-023-01107-5","article-title":"Mitofusin2 expression is associated with podocyte injury in IgA nephropathy","volume":"28","author":"Tang","year":"2023","journal-title":"Eur J Med Res"},{"issue":"2","key":"10.1016\/j.jacl.2026.03.020_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cell.2010.02.026","article-title":"Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations","volume":"141","author":"Chen","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jacl.2026.03.020_bib23","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202402921","article-title":"The MFN2 Q367H variant reveals a novel pathomechanism connected to mtDNA-mediated inflammation","volume":"8","author":"Zaman","year":"2025","journal-title":"Life Sci Alliance"},{"issue":"12","key":"10.1016\/j.jacl.2026.03.020_bib24","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/CIRCRESAHA.111.258723","article-title":"Mitochondrial fusion is essential for organelle function and cardiac homeostasis","volume":"109","author":"Chen","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2026.03.020_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84235","article-title":"A human mitofusin 2 mutation can cause mitophagic cardiomyopathy","volume":"12","author":"Franco","year":"2023","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.020_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11892-025-01603-4","article-title":"Clinical Guidance for Lipodystrophy Syndromes: From Diagnosis and Work-Up to Treatment","volume":"25","author":"Gilio","year":"2025","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.020_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11892-025-01602-5","article-title":"Lipodystrophy Syndromes: One Name but Many Diseases Highlighting the Importance of Adipose Tissue in Metabolism","volume":"25","author":"Foss-Freitas","year":"2025","journal-title":"Curr Diab Rep"},{"issue":"42","key":"10.1016\/j.jacl.2026.03.020_bib28","doi-asserted-by":"crossref","first-page":"E6418","DOI":"10.1073\/pnas.1614467113","article-title":"Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in mice","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6748","key":"10.1016\/j.jacl.2026.03.020_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jacl.2026.03.020_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1194\/jlr.M045799","article-title":"Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-\/- lipodystrophic mice independent of hepatocyte leptin receptors","volume":"55","author":"Cort\u00e9s","year":"2014","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.jacl.2026.03.020_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jacl.2026.03.020_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jacl.2026.03.020_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/dom.12606","article-title":"One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes","volume":"18","author":"Vatier","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.020_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13023-019-1141-2","article-title":"Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes","volume":"14","author":"Vatier","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.020_bib35","article-title":"12436 Madelung\u2019S multiple symmetric lipomatosis: a new indication for leptin pathway activation?","volume":"8","author":"de Freitas","year":"2024"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T22:44:11Z","timestamp":1780785851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1933287426000930"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.03.020","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel MFN2 compound heterozygote genotype in a patient with multiple symmetric lipomatosis and metabolic dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}